低分子量肝素对子痫前期产妇产后凝血指标的影响*

doi:10.3969/j.issn.1671-2587.2022.01.006

临床输血与检验 ›› 2022, Vol. 24 ›› Issue (1): 28-32.DOI: 10.3969/j.issn.1671-2587.2022.01.006

• 妇产科儿科输血专题（三） • 上一篇下一篇

低分子量肝素对子痫前期产妇产后凝血指标的影响*

徐畅, 王秋实

110004 中国医科大学附属盛京医院

收稿日期:2021-07-27 发布日期:2022-01-27
通讯作者: 王秋实,女,主任医师,博士,主要从事胎母免疫研究,（E-mail）qswang@cmu.edu.cn。
作者简介:徐畅（1995-）,女,吉林临江人,技师,硕士,主要从事妇产科输血研究,（E-mail）cxu@cmu.edu.cn。
基金资助:
*本课题受辽宁省科技厅病理妊娠患者分层血液管理平台的建设项目（No.2021JH2-10300045）资助

The Effect of a Low Molecular Weight Heparin on Postpartum Coagulation Parameters in Women with Preeclampsia

XU Chang, WANG Qiu-shi

Department of Blood Transfusion,Shengjing Hospital of China Medical University,Shenyang 110004

Received:2021-07-27 Published:2022-01-27

摘要/Abstract

摘要： 目的探讨低分子量肝素在子痫前期患者中的应用效果。方法回顾性调查我院2019年1~4月290例子痫前期患者,根据产后1 d采用的治疗方法分为肝素组（190例）及对照组（100例）,分析比较两组的一般资料和凝血指标差异。结果肝素组的新生儿体重和Apgar评分（1 min）低于对照组（P<0.05）。肝素组与对照组在产前仅凝血酶时间、D-二聚体、血小板体积分布宽度有差异,产后1 d肝素组纤维蛋白原含量、血小板计数、血小板压积低于对照组,凝血酶时间、D-二聚体、血小板体积分布宽度高于对照组（P<0.05）。产后3 d仅D-二聚体有差异。结论在产后1 d应用低分子量肝素有助于子痫前期患者产后凝血状态向正常恢复。

关键词: 子痫前期, 凝血, 低分子量肝素, DIC

Abstract: Objective To investigate the effect of a low molecular weight heparin in the treatment of patients with preeclampsia. Methods A retrospective investigation for 290 preeclampsia patients in our hospital was conducted from January to April 2019. These patients were divided into heparin group（190 cases）and control group（100 cases） based on treatment method adopted at the first day postpartum. The differences in general data and blood coagulation parameters between two groups were analyzed. Results Neonatal weight and Apgar score（1 min） in heparin group were lower than those in control group（P<0.05）. In levels of coagulation parameters,only thrombin time,D-dimer and platelet distribution width were different between heparin group and control group before delivery. On postpartum day 1, fibrinogen,platelet count and plateletcrit in heparin group were lower than those in control group,while thrombin time, D-dimer and platelet distribution width were higher（P<0.05）. On postpartum day 3,only D-dimer was different between two groups. Conclusion Low molecular weight heparin used on postpartum day 1 can help patients with preeclampsia to return to normal postpartum coagulation parameters.

Key words: Preeclampsia, Coagulation, Low molecular weight heparin, DIC

中图分类号:

R714

徐畅, 王秋实. 低分子量肝素对子痫前期产妇产后凝血指标的影响*[J]. 临床输血与检验, 2022, 24(1): 28-32.

XU Chang, WANG Qiu-shi. The Effect of a Low Molecular Weight Heparin on Postpartum Coagulation Parameters in Women with Preeclampsia[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(1): 28-32.

参考文献

[1] CHAPPELL LC, CLUVER CA, KINGDOM J, et al.Pre-eclampsia[J]. Lancet. 2021,398(10297):341-354.
[2] SHAH S, GUPTA A.Hypertensive Disorders of Pregnancy[J]. Cardiol Clin, 2019,37(3):345-354.
[3] HUANG J Z,CHEN X H,XING H Y,et al.Aspirin and heparin for the prevention of pre-eclampsia:protocol for a systematic review and network meta-analysis[J]. BMJ Open,2019,9(2):e026920.
[4] KILICCI C,OZKAYA E,KARAKUS R,et al.Early low molecular weight heparin for postpartum hemorrhage in women with pre-eclampsia. Is it effective to prevent consumptive coagulopathy?[J]. J Matern Fetal Neonatal Med,2020,33(3):410-414.
[5] 李笑天,狄文,古航,等. 上海市产科静脉血栓栓塞症防治的专家共识[J]. 上海医学,2020,43(11):645-650.
[6] 中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J].中华妇产科杂志,2020,55(4): 227-238.
[7] 李昀晖,王秋实,徐畅,等.足月单胎孕妇血栓弹力图与常规凝血试验参考区间的建立及相关性分析[J].中国输血杂志,2020,33(4):332-335.
[8] STAFF A C.The two-stage placental model of preeclampsia:an update[J].J Reprod Immunol,2019,134/135:1-10.
[9] HELOU A,WALKER S,STEWART K,et al.Management of pregnancies complicated by hypertensive disorders of pregnancy:could we do better?[J].Aust N Z J Obstet Gynaecol,2017,57(3):253-259.
[10] XU C,LI Y H,ZHANG W,et al.Analysis of perinatal coagulation function in preeclampsia[J]. Medicine,2021,100(26):e26482.
[11] 狄文,吴珈悦. 重视妇产科疾病诊疗过程中的抗凝问题[J]. 上海医学,2021,44(6):371-374.
[12] HAN M,LIU D,ZEB S,et al.Are maternal and neonatal outcomes different in placental abruption between women with and without preeclampsia?[J]. Placenta,2019,85:69-73.
[13] GUNES V,ONMAZ A C,KELES I,et al.The diagnostic importance of coagulation parameters in cattle having natural theileriosis[J]. Pol J Vet Sci,2017,20(2):369-376.
[14] KEIKKALA E,FORSTÉN J,RITVOS O,et al. Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women[J]. Pregnancy Hypertens,2021,25:116-122.

[1]	周璐洁, 陈绍恒, 张琦, 夏荣. 肝移植患者术中用血及相关指标综合分析*[J]. 临床输血与检验, 2022, 24(1): 58-62.
[2]	王文静, 刘希曦, 芦宏凯, 王琪, 王璐璐, 郭伟洁, 曹永彤. 肺移植患者围术期输血的影响因素分析[J]. 临床输血与检验, 2021, 23(5): 556-560.
[3]	耿文艳, 罗冰, 李晓丹, 肖晴, 黄小亭, 毛曼. 大量输血方案在严重产后出血中的应用探讨[J]. 临床输血与检验, 2021, 23(5): 604-607.
[4]	司念, 李可, 魏晴. 体外膜肺氧合支持下的输血策略[J]. 临床输血与检验, 2021, 23(4): 412-415.
[5]	蒋晓敏, 周小娟, 李意. CXCL12/CXCR4与子痫前期及其肝功能异常的相关性研究^*[J]. 临床输血与检验, 2021, 23(4): 482-487.
[6]	陈静, 童新元. 凝血因子、抗凝血酶、PLG、vWF及凝血象检测结果与TEG常用参数间的相关性研究[J]. 临床输血与检验, 2021, 23(3): 345-349.
[7]	许倩文, 薛磊, 汪敏, 强萍, 王丽, 徐慧, 张旭晗, 许汉英, 刘欣, 朱薇波, 蔡晓燕, 刘会兰, 孙自敏, 杨林, 王兴兵. 嵌合抗原受体T细胞治疗血液肿瘤所致凝血障碍及相关因素分析^*[J]. 临床输血与检验, 2021, 23(3): 364-370.
[8]	刘倩, 王笑欢, 郭凯, 牛子健, 宋珊珊, 郭婧, 马曙轩. 新生儿换血前后实验室指标的变化趋势^*[J]. 临床输血与检验, 2021, 23(2): 177-180.
[9]	姜同灿, 方章华, 任俊娇, 陶峰, 陈红波. 早孕期稽留流产患者凝血功能变化及危险因素分析^*[J]. 临床输血与检验, 2021, 23(2): 227-231.
[10]	黄佳丽, 刘正婷, 陈尚良, 周义文. 亚甲蓝光病毒灭活血浆的研究进展^*[J]. 临床输血与检验, 2021, 23(2): 268-272.
[11]	李昀晖, 徐畅, 张文, 王秋实. 凝血指标在病理性妊娠诊治中的应用价值^*[J]. 临床输血与检验, 2021, 23(1): 127-131.
[12]	余凤秀, 李津杞, 朱燕霞, 郭菲, 周载鑫, 顾海慧, 钱宝华. 二次重度离心制备法对冷沉淀凝血因子质量的影响^*[J]. 临床输血与检验, 2020, 22(5): 477-480.
[13]	朱跃跃, 卞茂红. 红细胞微粒及其生物学性质的研究进展[J]. 临床输血与检验, 2020, 22(5): 551-556.
[14]	连萍红, 陈丰梅, 彭红. 贮存式自体输血对非停跳冠状动脉旁路移植术患者免疫功能及术后恢复的影响[J]. 临床输血与检验, 2020, 22(4): 390-393.
[15]	孙小媛, 徐文莹, 王海燕. 妊娠晚期孕妇自体全血保存期间血液质量变化[J]. 临床输血与检验, 2020, 22(3): 264-268.

低分子量肝素对子痫前期产妇产后凝血指标的影响*

The Effect of a Low Molecular Weight Heparin on Postpartum Coagulation Parameters in Women with Preeclampsia

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们